HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome.

AbstractBACKGROUND:
The undercarboxylated form of osteocalcin (ucOC) is an emerging marker of cardiovascular disease. It is unknown if ucOC in related to common cardiovascular risk markers in children. In offspring of families with and without metabolic syndrome (MetS+ and MetS- families), we assessed whether ucOC was related to a continuous metabolic syndrome score (MetS score) and to carotid intima-media thickness (cIMT).
METHODS:
ucOC and total OC, MetS score and cIMT were assessed in 203 asymptomatic prepubertal children (age 7.6 ± 0.1 yr; 49% girls), of whom 99 were from MetS+ families.
RESULTS:
In children from MetS+ families, percent ucOC was higher than in children from MetS- families (p < 0.01). In offspring from MetS+ families, higher ucOC and especially higher percent ucOC was independently associated with both the MetS score and cIMT (both p ≤ 0.01).
CONCLUSIONS:
The undercarboxylated form of OC is related to common cardiovascular risk markers in children at risk for cardiovascular disease.
AuthorsAnna Prats-Puig, Inés Osiniri, Pilar Soriano-Rodríguez, Gemma Carreras-Badosa, José Cristóbal Buñuel-Álvarez, Carmen Vila-Pablos, Francis de Zegher, Lourdes Ibáñez, Judit Bassols, Abel López-Bermejo
JournalAtherosclerosis (Atherosclerosis) Vol. 233 Issue 1 Pg. 272-7 (Mar 2014) ISSN: 1879-1484 [Electronic] Ireland
PMID24529156 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Osteocalcin
Topics
  • Cardiovascular Diseases (etiology)
  • Carotid Intima-Media Thickness
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Metabolic Syndrome (complications)
  • Osteocalcin (blood, metabolism)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: